http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 27 May 2026 08:35:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Press+Releases/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html <p> <b><i>These evidence-based solutions help employers, brokers, and unions tackle cardiovascular disease, a leading driver of medical claims and lost productivity</i>.</b> </p> <p> CHICAGO--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcdio.ai%2F&amp;esheet=54542494&amp;newsitemid=20260527302873&amp;lan=en-US&amp;anchor=Cardio+Diagnostics+Holdings%2C+Inc.&amp;index=1&amp;md5=13b8634d937fe5c199f10f81e762f998" shape="rect">Cardio Diagnostics Holdings, Inc.</a> (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the company will exhibit at four upcoming national benefits conferences, connecting with employers, brokers, union trustees, and plan administrators on a shared challenge: cardiovascular disease (CVD). CVD remains a leading medical claims cost driver for most health plans and a major contributor to absenteeism, disability, and lost workforce productivity. </p><p> Cardio Diagnostics’ clinically validated blood tests, Epi+Gen CHD™ and http://www.streetinsider.com/Business+Wire/Cardio+Diagnostics+Holdings%2C+Inc.+to+Showcase+Precision+Cardiovascular+Solutions+at+Four+National+Benefits+Conferences+in+June/26554147.html Wed, 27 May 2026 08:35:00 -0400 A.60012013 CDIO O.07020545 O.52968319 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31/26506819.html si-local-file:///var/storage/secattach/20260515/26506819.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31/26506819.html Fri, 15 May 2026 16:39:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31/26506819.html si-local-file:///var/storage/secattach/20260515/26506819.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31/26506819.html Fri, 15 May 2026 16:39:00 -0400 CDIO O.52968319 http://www.streetinsider.com/Press+Releases/IBN+Initiates+Coverage+of+Cardio+Diagnostics+Holdings+Inc./26286639.html <p>AUSTIN, Texas, April 08, 2026 (GLOBE NEWSWIRE) -- via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ayxDyZA_WVGu0KsaDUFH4EcCqMAGiIdpjJVQdiPeSVnrAODmdhPPQ0X4tW4wrsU7EEsWEuUj87nxFcloyapEsgpppHLU4Jmw9RiZannicRQ=" rel="nofollow" target="_blank">IBN</a> -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=JeTVHkfG6zr94hh_Q1XWa4Dy5f8EC1EaI2SoNk9ARjqtj6JeDO4ih32UGrc9xMRxbPrG9TraEatr5gqRTz6r-G-yLA3BDIEFjt7vFN2Baq1wkcuguuJNGd-afooTO8algIgsllnkrYGPH74VcunF4v-H3Cx_DmkLqJXkm2e8xxrNF0aVRmOIJKhW9TcZxQWs1OXjE8O0TzrpgW4jfMKoWQ==" rel="nofollow" target="_blank">Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO)</a>, a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for the prevention and detection of cardiovascular disease, has engaged <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ABt0932DNB8jMnilsFx2mvG5JYYgBAnlTC6PnflJq9u1yZJQ6MQSKL3U4LHp0WkFZA_JxRFhfryERz-41CsPxS1ikwI81uDwfBrnDsbX7K0=" rel="nofollow" target="_blank">IBN</a>, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.</p> <p>Cardio Diagnostics develops and commercializes blood-based clinical tests and data solutions designed to support the prevention, detection, and management of cardiovascular disease. Its approach integrates epigenetic and genetic http://www.streetinsider.com/Press+Releases/IBN+Initiates+Coverage+of+Cardio+Diagnostics+Holdings+Inc./26286639.html Wed, 08 Apr 2026 08:30:00 -0400 CDIO O.52968319 http://www.streetinsider.com/Press+Releases/IBN+Initiates+Coverage+of+Cardio+Diagnostics+Holdings+Inc./26286639.html <p>AUSTIN, Texas, April 08, 2026 (GLOBE NEWSWIRE) -- via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ayxDyZA_WVGu0KsaDUFH4EcCqMAGiIdpjJVQdiPeSVnrAODmdhPPQ0X4tW4wrsU7EEsWEuUj87nxFcloyapEsgpppHLU4Jmw9RiZannicRQ=" rel="nofollow" target="_blank">IBN</a> -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=JeTVHkfG6zr94hh_Q1XWa4Dy5f8EC1EaI2SoNk9ARjqtj6JeDO4ih32UGrc9xMRxbPrG9TraEatr5gqRTz6r-G-yLA3BDIEFjt7vFN2Baq1wkcuguuJNGd-afooTO8algIgsllnkrYGPH74VcunF4v-H3Cx_DmkLqJXkm2e8xxrNF0aVRmOIJKhW9TcZxQWs1OXjE8O0TzrpgW4jfMKoWQ==" rel="nofollow" target="_blank">Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO)</a>, a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for the prevention and detection of cardiovascular disease, has engaged <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ABt0932DNB8jMnilsFx2mvG5JYYgBAnlTC6PnflJq9u1yZJQ6MQSKL3U4LHp0WkFZA_JxRFhfryERz-41CsPxS1ikwI81uDwfBrnDsbX7K0=" rel="nofollow" target="_blank">IBN</a>, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.</p> <p>Cardio Diagnostics develops and commercializes blood-based clinical tests and data solutions designed to support the prevention, detection, and management of cardiovascular disease. Its approach integrates epigenetic and genetic http://www.streetinsider.com/Press+Releases/IBN+Initiates+Coverage+of+Cardio+Diagnostics+Holdings+Inc./26286639.html Wed, 08 Apr 2026 08:30:00 -0400 CDIO O.52968319 http://www.streetinsider.com/Globe+Newswire/IBN+Initiates+Coverage+of+Cardio+Diagnostics+Holdings+Inc./26286639.html <p>AUSTIN, Texas, April 08, 2026 (GLOBE NEWSWIRE) -- via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ayxDyZA_WVGu0KsaDUFH4EcCqMAGiIdpjJVQdiPeSVnrAODmdhPPQ0X4tW4wrsU7EEsWEuUj87nxFcloyapEsgpppHLU4Jmw9RiZannicRQ=" rel="nofollow" target="_blank">IBN</a> -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=JeTVHkfG6zr94hh_Q1XWa4Dy5f8EC1EaI2SoNk9ARjqtj6JeDO4ih32UGrc9xMRxbPrG9TraEatr5gqRTz6r-G-yLA3BDIEFjt7vFN2Baq1wkcuguuJNGd-afooTO8algIgsllnkrYGPH74VcunF4v-H3Cx_DmkLqJXkm2e8xxrNF0aVRmOIJKhW9TcZxQWs1OXjE8O0TzrpgW4jfMKoWQ==" rel="nofollow" target="_blank">Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO)</a>, a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for the prevention and detection of cardiovascular disease, has engaged <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ABt0932DNB8jMnilsFx2mvG5JYYgBAnlTC6PnflJq9u1yZJQ6MQSKL3U4LHp0WkFZA_JxRFhfryERz-41CsPxS1ikwI81uDwfBrnDsbX7K0=" rel="nofollow" target="_blank">IBN</a>, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.</p> <p>Cardio Diagnostics develops and commercializes blood-based clinical tests and data solutions designed to support the prevention, detection, and management of cardiovascular disease. Its approach integrates epigenetic and genetic http://www.streetinsider.com/Globe+Newswire/IBN+Initiates+Coverage+of+Cardio+Diagnostics+Holdings+Inc./26286639.html Wed, 08 Apr 2026 08:30:00 -0400 CDIO O.52968319 http://www.streetinsider.com/Globe+Newswire/IBN+Initiates+Coverage+of+Cardio+Diagnostics+Holdings+Inc./26286639.html <p>AUSTIN, Texas, April 08, 2026 (GLOBE NEWSWIRE) -- via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ayxDyZA_WVGu0KsaDUFH4EcCqMAGiIdpjJVQdiPeSVnrAODmdhPPQ0X4tW4wrsU7EEsWEuUj87nxFcloyapEsgpppHLU4Jmw9RiZannicRQ=" rel="nofollow" target="_blank">IBN</a> -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=JeTVHkfG6zr94hh_Q1XWa4Dy5f8EC1EaI2SoNk9ARjqtj6JeDO4ih32UGrc9xMRxbPrG9TraEatr5gqRTz6r-G-yLA3BDIEFjt7vFN2Baq1wkcuguuJNGd-afooTO8algIgsllnkrYGPH74VcunF4v-H3Cx_DmkLqJXkm2e8xxrNF0aVRmOIJKhW9TcZxQWs1OXjE8O0TzrpgW4jfMKoWQ==" rel="nofollow" target="_blank">Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO)</a>, a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for the prevention and detection of cardiovascular disease, has engaged <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ABt0932DNB8jMnilsFx2mvG5JYYgBAnlTC6PnflJq9u1yZJQ6MQSKL3U4LHp0WkFZA_JxRFhfryERz-41CsPxS1ikwI81uDwfBrnDsbX7K0=" rel="nofollow" target="_blank">IBN</a>, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.</p> <p>Cardio Diagnostics develops and commercializes blood-based clinical tests and data solutions designed to support the prevention, detection, and management of cardiovascular disease. Its approach integrates epigenetic and genetic http://www.streetinsider.com/Globe+Newswire/IBN+Initiates+Coverage+of+Cardio+Diagnostics+Holdings+Inc./26286639.html Wed, 08 Apr 2026 08:30:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Fung+Peter+K/26265619.html si-local-file:///var/storage/secattach/20260402/26265619.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Fung+Peter+K/26265619.html Thu, 02 Apr 2026 14:22:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Fung+Peter+K/26265619.html si-local-file:///var/storage/secattach/20260402/26265619.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Fung+Peter+K/26265619.html Thu, 02 Apr 2026 14:22:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Betts+Wendy+J/26265594.html si-local-file:///var/storage/secattach/20260402/26265594.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Betts+Wendy+J/26265594.html Thu, 02 Apr 2026 14:18:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Betts+Wendy+J/26265594.html si-local-file:///var/storage/secattach/20260402/26265594.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Betts+Wendy+J/26265594.html Thu, 02 Apr 2026 14:18:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Intrater+James/26265523.html si-local-file:///var/storage/secattach/20260402/26265523.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Intrater+James/26265523.html Thu, 02 Apr 2026 14:08:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Intrater+James/26265523.html si-local-file:///var/storage/secattach/20260402/26265523.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Intrater+James/26265523.html Thu, 02 Apr 2026 14:08:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Burton+Paul+Frederick/26265482.html si-local-file:///var/storage/secattach/20260402/26265482.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Burton+Paul+Frederick/26265482.html Thu, 02 Apr 2026 14:03:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Burton+Paul+Frederick/26265482.html si-local-file:///var/storage/secattach/20260402/26265482.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cardio+Diagnostics+Holdi++For%3A+Mar+31++Filed+by%3A+Burton+Paul+Frederick/26265482.html Thu, 02 Apr 2026 14:03:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Cardio+Diagnostics+Holdi++For%3A+Dec+31/26160631.html si-local-file:///var/storage/secattach/20260313/26160631.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Cardio+Diagnostics+Holdi++For%3A+Dec+31/26160631.html Fri, 13 Mar 2026 17:19:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Cardio+Diagnostics+Holdi++For%3A+Dec+31/26160631.html si-local-file:///var/storage/secattach/20260313/26160631.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Cardio+Diagnostics+Holdi++For%3A+Dec+31/26160631.html Fri, 13 Mar 2026 17:19:00 -0400 CDIO O.52968319 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cardio+Diagnostics+Holdi++For%3A+Feb+19/26026344.html si-local-file:///var/storage/secattach/20260219/26026344.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cardio+Diagnostics+Holdi++For%3A+Feb+19/26026344.html Thu, 19 Feb 2026 08:01:00 -0400 CDIO O.52968319